Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression
- 1 October 1997
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 27 (10) , 1175-1183
- https://doi.org/10.1111/j.1365-2222.1997.tb01155.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cellsAllergy, 1995
- ICAM‐1/CD54 expression on conjunctival epithelium during pollen seasonAllergy, 1995
- Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena.American Journal of Respiratory and Critical Care Medicine, 1994
- Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposureJournal of Allergy and Clinical Immunology, 1994
- LoratadineDrugs, 1994
- The role of adhesion molecules in human eosinophil and basophil recruitmentJournal of Allergy and Clinical Immunology, 1994
- CC chemokines in allergic inflammationImmunology Today, 1994
- Adhesion molecules of allergic inflammation: recent insights into their functional rolesAllergy, 1994
- Allergic subjects express intercellular adhesion molecule — 1 (ICAMA or CD54) on epithelial cells of conjunctiva after allergen challengeJournal of Allergy and Clinical Immunology, 1993
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984